Vir Biotechnology, Inc. VIR Foreign — Total segment and consolidated revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept vir:RevenueFromContractWithCustomerExcludingAssessedTaxNet.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s foreign — total segment and consolidated revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s foreign — total segment and consolidated revenue?
- Vir Biotechnology, Inc. (VIR) reported foreign — total segment and consolidated revenue of -$41K in Q1 2026.
- What does foreign — total segment and consolidated revenue mean?
- This metric represents the total net revenue generated from customers located outside of the company's primary domestic market. It reflects the geographic diversification of the company's product sales and licensing agreements, providing insight into the scale of international commercial operations. Monitoring this figure helps investors assess the company's global market penetration and exposure to foreign regulatory and economic environments.